Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Asthma Control Assessment Via ACT and DRC in Asthmatics Treated With Seretide (50/250) Over 12 Weeks

NCT00363480 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00363480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00363480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Asthma Control Assessment Via ACT and DRC in Asthmatics Treated With Seretide (50/250) Over 12 Weeks
Lead sponsor
GlaxoSmithKline
Phase
Phase 4
Overall status
Completed
Start date
May 17, 2006
Completion date
September 14, 2007
Enrollment
221 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

asthma